Celldex Therapeutics Inc. Banner Image

Celldex Therapeutics Inc.

  • Ticker CLDX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Celldex Therapeutics Inc. Logo Image
  • 51-200 Employees
  • Based in Hampton, New Jersey
Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulatorsMore used in optimal combinations to create novel disease-specific drug candidates.
3.0 / 5.0 (3)

Celldex Therapeutics Inc. reports have an aggregate usefulness score of 3.0 based on 3 reviews.

Celldex Therapeutics Inc.

Most Recent Annual Report

Celldex Therapeutics Inc.
MOST RECENT 2023 Annual Report and Form 10K

Celldex Therapeutics Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Celldex Therapeutics Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!